Distributions of all expression values and Top 1% of expressed Boundary features for libraries: DLBCL, BCell1, BCell2, BCell3, BCell4, BCellPool

Download data matrix file (Boundary x library): BoundaryExpression_v53.txt.gz

Distribution of log2 expression values for library: DLBCL and data type: Boundary

Distribution of all expression values for the feature type: Boundary. Note that unlike in the individual gene pages these log2 expression values were not adjusted by adding 1 before converting to log2 scale. This results in -ve expression values if the average coverage of the feature was less than 1 before conversion to log2 scale. The 95th percentile of Silent Intergenic regions is reported to give an indication of the level of background expression noise. *If you can not see the figure below, click here

Distribution of log2 expression values for library: BCell1 and data type: Boundary

Distribution of log2 expression values for library: BCell2 and data type: Boundary

Distribution of log2 expression values for library: BCell3 and data type: Boundary

Distribution of log2 expression values for library: BCell4 and data type: Boundary

Distribution of log2 expression values for library: BCellPool and data type: Boundary

Top 1% of expressed Boundary features

The following table provides a ranked list of the most highly expressed Boundary features. Each column corresponds to an expression library. Each table cell contains the Gene Name (which links to the ALEXA-Seq gene record), followed by the Feature Name (which links to the feature's coordinates in the UCSC Genome Browser and displays expression data), the log2 expression value 'Exp' for the feature, and the percent expression value '% Exp' ([feature expression/gene expression]*100). For Gene records the percent displayed here represents the percentage of all reads for the library instead. Features that are NOT supported by an EST/mRNA sequence are indicated in bold. For exon junction features the number of exons skipped by the junction is indicated as 'Sn', where n is the number of exons skipped (e.g. S0 means no exons skipped, S1 means one exon skipped, etc.).

RANK	DLBCL (Gene \| Feature \| Exp \| % Exp)	BCell1 (Gene \| Feature \| Exp \| % Exp)	BCell2 (Gene \| Feature \| Exp \| % Exp)	BCell3 (Gene \| Feature \| Exp \| % Exp)	BCell4 (Gene \| Feature \| Exp \| % Exp)	BCellPool (Gene \| Feature \| Exp \| % Exp)
1	HLA-DRA \| E1_Ab \| 16.77 \| 146.45%	EEF1A1 \| E4_Da \| 16.81 \| 444.11%	EEF1A1 \| E4_Da \| 15.91 \| 329.94%	TMSL3 \| E1_Da \| 16.70 \| 4854.31%	UBC \| E2_Da \| 16.86 \| 419.68%	UBC \| E2_Da \| 16.36 \| 375.17%
2	EEF1A1 \| E5_Db \| 16.18 \| 228.92%	TMSL3 \| E1_Da \| 16.14 \| 5068.55%	UBC \| E2_Da \| 15.87 \| 322.37%	AC096663.1 \| E2_Aa \| 16.31 \| 26676.05%	UBC \| E2_Ak \| 16.50 \| 327.50%	UBC \| E2_Ak \| 16.05 \| 302.14%
3	AC002480.1 \| E2_Aa \| 16.17 \| 31338.94%	EEF1A1 \| E5_Db \| 15.92 \| 240.88%	HLA-DRA \| E1_Ab \| 15.67 \| 123.12%	EEF1A1 \| E4_Da \| 16.09 \| 283.42%	UBC \| E2_Dk \| 16.07 \| 243.77%	TMSL3 \| E1_Da \| 15.95 \| 2977.44%
4	TMSL3 \| E1_Da \| 15.81 \| 1554.33%	AC096663.1 \| E2_Aa \| 15.72 \| 42755.94%	UBC \| E2_Ak \| 15.48 \| 246.14%	UBC \| E2_Da \| 16.08 \| 463.44%	UBC \| E2_Dj \| 16.03 \| 237.07%	HLA-DRA \| E1_Ab \| 15.90 \| 89.66%
5	TMSB4X \| E2_Da \| 15.77 \| 124.27%	RPS6 \| E2_Dd \| 15.64 \| 290.92%	EEF1A1 \| E5_Db \| 15.39 \| 230.08%	RPS14 \| E2_Ab \| 16.05 \| 386.71%	HLA-DRA \| E1_Ab \| 15.99 \| 140.34%	EEF1A1 \| E4_Da \| 15.86 \| 212.15%
6	EEF1A1 \| E4_Da \| 15.61 \| 153.71%	HLA-DRA \| E1_Ab \| 15.63 \| 120.75%	TMSL3 \| E1_Da \| 15.31 \| 3182.03%	SERF2 \| E3_Ah \| 15.99 \| 1896.44%	RPL27 \| E2_Ab \| 15.59 \| 145.32%	AC096663.1 \| E2_Aa \| 15.69 \| 26022.69%
7	HLA-DRA \| E3_Ab \| 15.45 \| 58.82%	UBC \| E2_Da \| 15.60 \| 323.13%	UBC \| E2_Dk \| 15.08 \| 186.42%	HLA-DRA \| E1_Ab \| 15.96 \| 98.31%	UBC \| E2_Ab \| 15.55 \| 169.36%	RPS14 \| E2_Ab \| 15.65 \| 338.36%
8	RPS6 \| E2_Dd \| 15.43 \| 127.56%	ACTA1 \| E3_Da \| 15.53 \| 894443.99%	RPS6 \| E2_Dd \| 15.05 \| 183.84%	UBC \| E2_Ak \| 15.85 \| 396.12%	ACTA1 \| E3_Dc \| 15.46 \| 730649.74%	UBC \| E2_Dk \| 15.60 \| 222.45%
9	HLA-DPA1 \| E2_Ac \| 15.40 \| 221.57%	UBC \| E2_Ak \| 15.37 \| 275.68%	RPS7 \| E2_Ab \| 14.94 \| 405.44%	RPS6 \| E2_Dd \| 15.79 \| 180.60%	UBC \| E2_Dc \| 15.44 \| 157.16%	EEF1A1 \| E5_Db \| 15.54 \| 169.40%
10	AL121759.25 \| E1_Da \| 15.25 \| 312020.67%	RPS7 \| E2_Ab \| 15.32 \| 414.50%	PTMA \| E2_Ad \| 14.79 \| 141.26%	EEF1A1 \| E5_Db \| 15.75 \| 224.43%	AC092268.4 \| E1_Da \| 15.32 \| 68107.00%	UBC \| E2_Dj \| 15.50 \| 206.80%
11	AL121759.25 \| E2_Aa \| 15.13 \| 285496.70%	SERF2 \| E3_Ah \| 15.17 \| 2224.71%	TMSL3 \| E1_Ab \| 14.74 \| 2131.98%	HLA-DRA \| E3_Ab \| 15.68 \| 80.96%	SERF2 \| E3_Ah \| 15.31 \| 1973.84%	SERF2 \| E3_Ah \| 15.44 \| 1719.20%
12	UBC \| E2_Da \| 15.05 \| 419.30%	TMSL3 \| E1_Ab \| 15.02 \| 2331.27%	AC096663.1 \| E2_Aa \| 14.72 \| 28178.19%	RPS7 \| E2_Ab \| 15.65 \| 350.72%	AC002480.1 \| E2_Aa \| 15.27 \| 47377.96%	RPS7 \| E2_Ab \| 15.35 \| 261.28%
13	RPL27 \| E2_Ab \| 14.97 \| 84.80%	UBC \| E2_Dk \| 15.01 \| 215.32%	UBC \| E2_Dj \| 14.67 \| 139.96%	TMSL3 \| E1_Ab \| 15.58 \| 2237.07%	RPS7 \| E2_Ab \| 15.19 \| 362.20%	RPS6 \| E2_Dd \| 15.26 \| 125.13%
14	AC096663.1 \| E1_Da \| 14.80 \| 13861.13%	AC002480.1 \| E2_Aa \| 14.62 \| 18389.96%	ACTA1 \| E3_Da \| 14.58 \| 236142.05%	AC010234.5 \| E3_Da \| 15.50 \| 1216809.08%	AC096663.1 \| E2_Aa \| 15.17 \| 55625.42%	HLA-DRA \| E3_Ab \| 15.19 \| 55.05%
15	AC011737.10 \| E1_Da \| 14.70 \| 179001.10%	UBC \| E2_Dj \| 14.61 \| 163.41%	AC002480.1 \| E2_Aa \| 14.57 \| 18358.78%	TMSB4X \| E2_Da \| 15.38 \| 124.27%	HLA-DRA \| E3_Ab \| 15.17 \| 79.26%	ACTA1 \| E3_Da \| 15.15 \| 338427.81%
16	RPS21 \| E2_Ac \| 14.65 \| 495.30%	AC096663.1 \| E1_Da \| 14.50 \| 18411.07%	PTMA \| E7_Dc \| 14.51 \| 116.41%	RPL27 \| E2_Ab \| 15.36 \| 100.89%	EEF1A1 \| E5_Db \| 15.16 \| 217.20%	RPL27 \| E2_Ab \| 15.14 \| 90.53%
17	DENND1B \| E4_Aa \| 14.59 \| 134859.49%	UBC \| E2_Ab \| 14.49 \| 150.17%	UBC \| E2_Dc \| 14.47 \| 121.84%	UBC \| E2_Dk \| 15.34 \| 277.39%	ACTA1 \| E3_Da \| 15.00 \| 529621.90%	AC002480.1 \| E2_Aa \| 15.11 \| 14034.31%
18	TOMM7 \| E1_Ab \| 14.56 \| 350.30%	UBC \| E2_Dc \| 14.48 \| 149.06%	UBC \| E2_Af \| 14.41 \| 116.87%	UBC \| E2_Dj \| 15.30 \| 270.04%	RPS21 \| E2_Ac \| 14.99 \| 640.90%	ACTA1 \| E3_Dc \| 15.05 \| 316182.72%
19	TPT1 \| E5_Da \| 14.56 \| 71.96%	HLA-DRA \| E3_Ab \| 14.46 \| 53.60%	UBC \| E2_Ab \| 14.31 \| 109.60%	ACTA1 \| E3_Da \| 15.30 \| 286449.26%	AC010234.5 \| E3_Da \| 14.96 \| 2512825.36%	TMSL3 \| E1_Ab \| 14.96 \| 1499.94%
20	HLA-A \| E6_Ac \| 14.56 \| 297.32%	EEF1A1 \| E9_Da \| 14.45 \| 86.76%	HLA-DRA \| E3_Ab \| 14.18 \| 43.83%	GAPDH \| E10_Da \| 15.29 \| 44.07%	AL121759.25 \| E1_Da \| 14.94 \| 381595.07%	AC010234.5 \| E3_Da \| 14.96 \| 1434787.85%
21	TPT1 \| E1_Ac \| 14.50 \| 69.04%	PTMA \| E7_Dc \| 14.41 \| 114.99%	GAPDH \| E10_Da \| 14.15 \| 38.71%	AC002480.1 \| E2_Aa \| 15.27 \| 10077.26%	GAPDH \| E10_Da \| 14.93 \| 49.96%	UBC \| E2_Ab \| 14.96 \| 142.06%
22	ACTA1 \| E3_Dc \| 14.37 \| 313454.01%	AL109615.42 \| E1_Da \| 14.40 \| 1775973.39%	HLA-DPA1 \| E2_Ac \| 14.13 \| 205.78%	AL109615.42 \| E1_Da \| 15.09 \| 1065490.28%	AC008629.7 \| E1_Da \| 14.92 \| 141499.51%	GAPDH \| E10_Da \| 14.89 \| 41.29%
23	UBC \| E2_Ak \| 14.33 \| 255.29%	ACTA1 \| E3_Dc \| 14.35 \| 395954.21%	UBC \| E2_Dd \| 14.10 \| 94.70%	GAPDH \| E10_Db \| 15.06 \| 37.58%	TMSL3 \| E1_Da \| 14.91 \| 5564.85%	UBC \| E2_Dc \| 14.88 \| 134.84%
24	AL354710.17 \| E2_Da \| 14.31 \| 124189.26%	TUBA1C \| E5_Ab \| 14.32 \| 1052.78%	ACTA1 \| E3_Dc \| 14.08 \| 166328.37%	ACTA1 \| E3_Dc \| 15.04 \| 240108.08%	TMSB4X \| E2_Da \| 14.88 \| 138.46%	TMSB4X \| E2_Da \| 14.87 \| 86.03%
25	AC092268.4 \| E1_Da \| 14.19 \| 39848.46%	UBC \| E2_Af \| 14.25 \| 126.89%	TMSB4X \| E2_Da \| 13.97 \| 85.51%	EEF1A1 \| E9_Da \| 14.99 \| 132.93%	UBC \| E2_Af \| 14.87 \| 105.65%	RPS21 \| E2_Ac \| 14.67 \| 463.42%
26	EEF1A1 \| E9_Da \| 14.18 \| 56.95%	PTMA \| E2_Ad \| 14.24 \| 102.26%	PTMA \| E7_De \| 13.94 \| 78.36%	RPS21 \| E2_Ac \| 14.89 \| 555.53%	UBC \| E2_Dd \| 14.83 \| 103.27%	AC096663.1 \| E1_Da \| 14.50 \| 11439.65%
27	AL354710.17 \| E3_Aa \| 14.17 \| 112816.91%	HLA-DPA1 \| E2_Ac \| 14.15 \| 169.28%	PTMA \| E4_Ab \| 13.89 \| 75.82%	RPS4X \| E6_Da \| 14.88 \| 48.46%	AC004448.3 \| E1_Da \| 14.80 \| 58851.65%	AC004448.3 \| E1_Da \| 14.48 \| 5020.17%
28	AC022443.5 \| E2_Aa \| 14.16 \| 53126.49%	EEF1A1 \| E9_Db \| 14.12 \| 69.20%	AC096663.1 \| E1_Da \| 13.88 \| 15720.57%	AC096663.1 \| E1_Da \| 14.80 \| 9383.08%	TPT1 \| E1_Ac \| 14.80 \| 213.48%	UBC \| E2_Af \| 14.44 \| 99.58%
29	HLA-DPB1 \| E6_Ac \| 14.06 \| 89.01%	UBC \| E2_Dd \| 14.11 \| 115.10%	GAPDH \| E2_Ac \| 13.82 \| 30.72%	AC008629.7 \| E1_Da \| 14.69 \| 26002.79%	EEF1A1 \| E4_Da \| 14.77 \| 165.98%	AC092268.4 \| E1_Da \| 14.44 \| 20834.00%
30	AC096663.1 \| E2_Aa \| 14.06 \| 8300.95%	RPS21 \| E2_Ac \| 14.08 \| 510.09%	TPT1 \| E1_Ac \| 13.82 \| 84.27%	AC010234.5 \| E4_Aa \| 14.69 \| 691717.39%	PTMA \| E4_Ab \| 14.68 \| 145.34%	TPT1 \| E1_Ac \| 14.43 \| 94.93%
31	EEF1A1 \| E9_Db \| 14.03 \| 51.42%	GAPDH \| E2_Ac \| 14.07 \| 30.11%	TUBA1C \| E5_Ab \| 13.78 \| 738.21%	AC004448.3 \| E1_Da \| 14.60 \| 9219.98%	HLA-DPA1 \| E2_Ac \| 14.56 \| 229.81%	AC008629.7 \| E1_Da \| 14.41 \| 36617.26%
32	HLA-DPA1 \| E4_Ab \| 14.02 \| 85.50%	GAPDH \| E10_Da \| 14.07 \| 30.03%	EEF1A1 \| E9_Db \| 13.76 \| 74.52%	TUBA1C \| E5_Ab \| 14.60 \| 841.55%	PTMA \| E2_Ad \| 14.52 \| 130.33%	AL109615.42 \| E1_Da \| 14.41 \| 850045.45%
33	ATP5E \| E1_Ac \| 14.02 \| 819.90%	TPT1 \| E1_Ac \| 13.93 \| 81.85%	PTMA \| E7_Dd \| 13.74 \| 68.26%	CSMD3 \| E3_Aa \| 14.51 \| 108080867.83%	AC011737.10 \| E1_Da \| 14.42 \| 195398.02%	PTMA \| E2_Ad \| 14.38 \| 90.55%
34	PTMA \| E7_Dc \| 14.00 \| 142.05%	PTMA \| E7_De \| 13.91 \| 81.56%	AC092268.4 \| E2_Ab \| 13.73 \| 35824.39%	PTMA \| E4_Ab \| 14.44 \| 87.32%	AC096663.1 \| E1_Da \| 14.39 \| 32308.36%	EEF1A1 \| E9_Da \| 14.35 \| 74.54%
35	COMMD6 \| E2_Ac \| 13.91 \| 1071.67%	AC092268.4 \| E2_Aa \| 13.89 \| 38003.63%	AC004448.3 \| E1_Da \| 13.69 \| 27436.52%	UBC \| E2_Ab \| 14.42 \| 146.64%	BX323046.3 \| E1_Da \| 14.36 \| 835519.35%	UBC \| E2_Dd \| 14.35 \| 92.99%
36	UBC \| E2_Dk \| 13.90 \| 189.02%	IGHA1 \| E2_Aa \| 13.84 \| 31.54%	EEF1A1 \| E9_Da \| 13.66 \| 69.38%	EEF1A1 \| E9_Ab \| 14.41 \| 88.95%	RPS6 \| E2_Dd \| 14.34 \| 96.83%	PTMA \| E4_Ab \| 14.32 \| 86.93%
37	SERF2 \| E3_Ah \| 13.87 \| 1458.38%	LDHB \| E1_Ab \| 13.81 \| 325.29%	SERF2 \| E3_Ah \| 13.59 \| 948.59%	BX323046.3 \| E1_Da \| 14.41 \| 275392.46%	HSPA8 \| E7_Da \| 14.33 \| 70.98%	GAPDH \| E10_Db \| 14.31 \| 27.73%
38	HLA-DPB1 \| E6_Ab \| 13.87 \| 77.72%	RPS14 \| E2_Ab \| 13.78 \| 189.03%	HSP90AB3P \| E3_Da \| 13.58 \| 70907.82%	PTMA \| E6_Ac \| 14.38 \| 83.44%	PTMA \| E2_Ae \| 14.29 \| 111.00%	HLA-DPA1 \| E2_Ac \| 14.22 \| 133.60%
39	PTMA \| E7_Dd \| 13.85 \| 128.06%	TMSB4X \| E2_Da \| 13.71 \| 74.80%	HLA-A \| E6_Ac \| 13.57 \| 526.56%	PTMA \| E4_Db \| 14.37 \| 82.83%	PTMA \| E4_Db \| 14.24 \| 106.92%	PTMA \| E7_Dc \| 14.19 \| 79.68%
40	RPS27A \| E6_Da \| 13.71 \| 41.75%	UBC \| E2_Ac \| 13.71 \| 87.42%	AL109615.42 \| E1_Da \| 13.57 \| 586425.12%	AC092268.4 \| E2_Ab \| 14.36 \| 11173.90%	AL121759.25 \| E2_Aa \| 14.20 \| 229357.71%	TUBA1C \| E5_Ab \| 14.18 \| 693.03%
41	TMSL3 \| E1_Ab \| 13.71 \| 360.89%	AC092268.4 \| E2_Ab \| 13.70 \| 33320.32%	AC092268.4 \| E2_Db \| 13.54 \| 31374.05%	RP11-753C18.4 \| E1_Da \| 14.36 \| 2252848.78%	HLA-A \| E6_Ac \| 14.19 \| 407.84%	CSMD3 \| E3_Aa \| 14.17 \| 90486982.08%
42	AC008481.9 \| E1_Da \| 13.69 \| 186700.15%	RPL27 \| E2_Ab \| 13.70 \| 77.00%	GAPDH \| E10_Db \| 13.53 \| 25.24%	AL109615.42 \| E2_Aa \| 14.35 \| 636637.36%	HSP90AB1 \| E11_Db \| 14.16 \| 93.23%	AC010234.5 \| E4_Aa \| 14.14 \| 809294.79%
43	CSMD3 \| E3_Aa \| 13.68 \| 92149944.95%	AC004448.3 \| E1_Da \| 13.64 \| 15242.17%	HMGB1L15 \| E1_Dc \| 13.52 \| 2141.30%	TPT1 \| E1_Ac \| 14.34 \| 121.78%	TMSL3 \| E1_Ab \| 14.15 \| 3285.57%	HSPA8 \| E7_Da \| 14.11 \| 64.56%
44	ACTA1 \| E3_Da \| 13.63 \| 188252.80%	HLA-A \| E6_Ac \| 13.63 \| 834.36%	AC092268.4 \| E1_Da \| 13.44 \| 29266.67%	UBC \| E2_Dc \| 14.29 \| 134.42%	AL121893.21 \| E2_Aa \| 14.13 \| 324758.94%	BX323046.3 \| E1_Da \| 14.07 \| 237111.60%
45	AL671277.5 \| E8_Da \| 13.62 \| 15979.85%	HSPA8 \| E7_Da \| 13.57 \| 53.75%	RPL27 \| E2_Ab \| 13.43 \| 61.53%	HSPA8 \| E7_Da \| 14.27 \| 93.99%	AC010234.5 \| E4_Aa \| 14.12 \| 1405159.81%	PTMA \| E4_Db \| 14.01 \| 70.34%
46	PTMA \| E2_Ad \| 13.58 \| 106.01%	TPT1 \| E5_Da \| 13.54 \| 62.43%	UBC \| E2_Ac \| 13.43 \| 59.37%	RPL18A \| E3_Aa \| 14.26 \| 85.69%	HSP90AB3P \| E3_Da \| 14.10 \| 122349.20%	AC092268.4 \| E2_Ab \| 13.99 \| 15192.79%
47	RPL5 \| E1_Ab \| 13.57 \| 39.17%	HSPA8 \| E9_Da \| 13.52 \| 51.99%	TPT1 \| E5_Da \| 13.38 \| 62.25%	PTMA \| E7_Dc \| 14.25 \| 76.27%	DENND1B \| E4_Aa \| 14.09 \| 76349.57%	HLA-A \| E6_Ac \| 13.99 \| 295.78%
48	EEF1B2 \| E1_Ad \| 13.57 \| 182.67%	AC092268.4 \| E1_Da \| 13.50 \| 28938.69%	HSPA8 \| E7_Da \| 13.38 \| 50.67%	TUBA1C \| E5_Da \| 14.23 \| 651.31%	HSP90AB1 \| E13_Ab \| 14.00 \| 83.52%	AL121759.25 \| E1_Da \| 13.98 \| 97401.06%
49	FAU \| E3_Ab \| 13.57 \| 97.00%	AL121893.21 \| E2_Aa \| 13.49 \| 232638.78%	AC010234.5 \| E3_Da \| 13.37 \| 730560.48%	RPS29 \| E3_Da \| 14.20 \| 125.76%	UBC \| E2_Ah \| 14.00 \| 58.04%	AL121893.21 \| E2_Aa \| 13.89 \| 124517.49%
50	UBC \| E2_Dc \| 13.55 \| 147.96%	H3F3A \| E5_Da \| 13.48 \| 3746.74%	HNRPA2B1 \| E6_Da \| 13.35 \| 159.27%	AC092268.4 \| E2_Aa \| 14.12 \| 9418.61%	TUBA1C \| E5_Da \| 13.97 \| 643.29%	AL109615.42 \| E2_Aa \| 13.88 \| 588224.47%
51	PTMA \| E4_Ab \| 13.44 \| 96.34%	HSP90AB3P \| E3_Da \| 13.47 \| 100926.24%	HLA-DMA \| E1_Ac \| 13.33 \| 133.78%	RPL13A \| E9_Da \| 14.11 \| 41.11%	HSPA8 \| E9_Ab \| 13.93 \| 53.90%	GAPDH \| E2_Ac \| 13.88 \| 20.51%
52	HLA-DPB1 \| E6_Da \| 13.38 \| 55.58%	AL109615.42 \| E2_Aa \| 13.46 \| 925481.85%	RPL5 \| E1_Ab \| 13.32 \| 59.08%	AL121893.21 \| E2_Aa \| 14.09 \| 97217.67%	RPS21 \| E3_Dd \| 13.91 \| 302.79%	TUBA1C \| E5_Da \| 13.87 \| 558.58%
53	AC020898.6 \| E2_Da \| 13.34 \| 15355.61%	SERF2 \| E3_Af \| 13.43 \| 664.54%	TPT1 \| E1_Ad \| 13.26 \| 57.52%	AC016734.7 \| E2_Aa \| 14.03 \| 385381.34%	UBC \| E2_Al \| 13.89 \| 53.88%	PTMA \| E6_Ac \| 13.83 \| 62.09%
54	UBC \| E2_Dj \| 13.28 \| 122.62%	PTMA \| E7_Dd \| 13.42 \| 57.71%	CSMD3 \| E3_Aa \| 13.25 \| 20970285.43%	HLA-A \| E6_Ac \| 14.01 \| 383.43%	RPL18A \| E3_Aa \| 13.89 \| 114.76%	RP11-753C18.4 \| E1_Da \| 13.82 \| 1010437.96%
55	AD000092.1 \| E2_Aa \| 13.18 \| 56152.30%	BRCA1 \| E14_Da \| 13.40 \| 4366.79%	HSP90AB3P \| E3_Aa \| 13.20 \| 54688.38%	PTMA \| E2_Ad \| 13.99 \| 63.81%	PTMA \| E7_Dc \| 13.87 \| 83.01%	RPS4X \| E6_Da \| 13.80 \| 26.27%
56	RPL13A \| E9_Da \| 13.18 \| 28.72%	PKM2 \| E6_Ab \| 13.37 \| 79.96%	HSP90AA4P \| E3_Aa \| 13.18 \| 245362.39%	AP002364.4 \| E1_Da \| 13.94 \| 17619.94%	GAPDH \| E10_Db \| 13.86 \| 23.90%	AC011737.10 \| E1_Da \| 13.79 \| 76309.86%
57	HMGN1 \| E7_Db \| 13.18 \| 117.42%	RPL5 \| E1_Ab \| 13.36 \| 52.97%	HSP90AB3P \| E2_Da \| 13.16 \| 52990.25%	ATP5E \| E1_Ac \| 13.88 \| 900.97%	RP11-753C18.4 \| E1_Da \| 13.85 \| 3054603.68%	AC092268.4 \| E2_Aa \| 13.74 \| 12816.19%
58	UBC \| E2_Ab \| 13.18 \| 114.44%	HLA-DPA1 \| E4_Ab \| 13.35 \| 97.36%	HSP90AB1 \| E11_Db \| 13.16 \| 56.37%	IGHA2 \| E3_Db \| 13.87 \| 225.94%	UBC \| E2_Ac \| 13.83 \| 51.54%	RPL18A \| E3_Aa \| 13.72 \| 86.20%
59	UBC \| E2_Af \| 13.12 \| 110.31%	FCRLA \| E1_Ab \| 13.34 \| 282.88%	AL109615.42 \| E2_Aa \| 13.15 \| 439380.13%	HSPA8 \| E9_Ab \| 13.87 \| 71.30%	TOMM7 \| E1_Ab \| 13.83 \| 431.24%	HSP90AB3P \| E3_Da \| 13.71 \| 80851.55%
60	GAPDH \| E10_Da \| 13.10 \| 44.55%	IGHA2 \| E3_Db \| 13.30 \| 183.87%	BX323046.3 \| E1_Da \| 13.14 \| 260037.22%	UBC \| E2_Af \| 13.86 \| 99.70%	AC092268.4 \| E2_Ab \| 13.77 \| 23322.33%	HSPA8 \| E9_Ab \| 13.70 \| 48.47%
61	HLA-DPB1 \| E10_Aa \| 13.10 \| 45.72%	HMGB1L15 \| E1_Dc \| 13.26 \| 1462.11%	AC096506.5 \| E1_Da \| 13.13 \| 597248.79%	HSP90AB1 \| E13_Ab \| 13.85 \| 109.32%	GAPDH \| E9_Da \| 13.77 \| 22.41%	AL121759.25 \| E2_Aa \| 13.69 \| 79387.38%
62	PKM2 \| E2_Da \| 13.09 \| 121.13%	RPL13A \| E9_Da \| 13.25 \| 41.13%	H3F3A \| E5_Da \| 13.13 \| 3046.31%	WIPF1 \| E11_Db \| 13.83 \| 665.31%	FAU \| E3_Ab \| 13.76 \| 72.98%	HSP90AB1 \| E11_Db \| 13.66 \| 73.87%
63	UBC \| E2_Dd \| 13.09 \| 107.72%	PCNA \| E2_Ab \| 13.24 \| 223.57%	PKM2 \| E2_Da \| 13.12 \| 80.30%	AC104581.22 \| E2_Aa \| 13.81 \| 381931.30%	UBC \| E2_De \| 13.76 \| 48.98%	RPL13A \| E9_Da \| 13.63 \| 31.81%
64	HLA-A \| E4_Da \| 13.06 \| 105.48%	TPT1 \| E1_Ad \| 13.23 \| 50.30%	TUBA1C \| E5_Da \| 13.11 \| 464.35%	HLA-DPA1 \| E2_Ac \| 13.78 \| 143.43%	WIPF1 \| E11_Db \| 13.76 \| 528.28%	RPS29 \| E3_Da \| 13.62 \| 68.49%
65	TPT1 \| E5_Db \| 13.00 \| 24.32%	CSMD3 \| E3_Aa \| 13.21 \| 39572364.26%	IGHA1 \| E2_Aa \| 13.10 \| 33.90%	HSPA8 \| E9_Da \| 13.76 \| 66.22%	TUBA1C \| E5_Ab \| 13.74 \| 550.98%	HSP90AB1 \| E13_Ab \| 13.62 \| 71.81%
66	ZNF695 \| E4_Dc \| 12.99 \| 108191.32%	AC092268.4 \| E2_Db \| 13.19 \| 23373.37%	LDHB \| E1_Ab \| 13.10 \| 229.59%	UBC \| E2_Dd \| 13.75 \| 92.39%	AL109615.42 \| E1_Da \| 13.74 \| 1792090.66%	EEF1A1 \| E9_Ab \| 13.60 \| 44.20%
67	AC022443.5 \| E1_Da \| 12.99 \| 23522.76%	AC016734.7 \| E2_Aa \| 13.17 \| 465598.37%	HSPA8 \| E9_Da \| 13.09 \| 41.49%	AL121759.25 \| E2_Aa \| 13.75 \| 62258.15%	ACTA1 \| E3_Ab \| 13.73 \| 220243.61%	IGHA2 \| E3_Db \| 13.60 \| 252.86%
68	POLR2J2 \| E1_Ab \| 12.97 \| 1591.04%	HSP90AA4P \| E3_Aa \| 13.15 \| 471022.90%	UBC \| E2_Ah \| 13.04 \| 45.27%	AFMID \| E12_Db \| 13.74 \| 4552.37%	AL109615.42 \| E2_Aa \| 13.72 \| 1773920.91%	PTMA \| E2_Ae \| 13.55 \| 51.03%
69	PTMA \| E7_De \| 12.96 \| 69.13%	HSP90AB3P \| E3_Aa \| 13.15 \| 80651.25%	HSP90AA6P \| E1_Da \| 13.03 \| 127654.65%	AL589843.9 \| E3_Da \| 13.73 \| 55382.73%	IGHA2 \| E3_Db \| 13.70 \| 395.69%	HSPA8 \| E9_Da \| 13.55 \| 43.71%
70	TPT1 \| E1_Ad \| 12.95 \| 23.62%	CD52 \| E2_Aa \| 13.11 \| 95.85%	ARPC5 \| E1_Ac \| 13.03 \| 256.07%	EFHB \| E12_Da \| 13.72 \| 329899.59%	AC104581.22 \| E2_Aa \| 13.69 \| 382184.72%	UBC \| E2_Ac \| 13.54 \| 53.28%
71	AC010234.5 \| E3_Da \| 12.95 \| 629068.48%	HSP90AA6P \| E1_Da \| 13.10 \| 913332.75%	AC005000.2 \| E1_Da \| 12.98 \| 219.25%	AC011740.7 \| E4_Aa \| 13.68 \| 22668.67%	HNRNPC \| E3_Ab \| 13.68 \| 281.65%	AP002364.4 \| E1_Da \| 13.54 \| 24921.60%
72	IL2RG \| E1_Ad \| 12.94 \| 164.43%	HMGB1L15 \| E1_Ac \| 13.09 \| 1304.38%	HLA-DMA \| E1_Ad \| 12.97 \| 104.30%	AL354710.17 \| E2_Da \| 13.67 \| 134017.55%	EEF1A1 \| E9_Da \| 13.66 \| 76.95%	AC016734.7 \| E2_Aa \| 13.52 \| 379723.84%
73	HLA-DMA \| E1_Ac \| 12.90 \| 118.51%	HSPA8 \| E9_Ab \| 13.07 \| 38.11%	HLA-DPA1 \| E4_Ab \| 12.97 \| 91.64%	AC092268.4 \| E2_Db \| 13.67 \| 6901.38%	AL354710.17 \| E2_Da \| 13.65 \| 217813.16%	WIPF1 \| E11_Db \| 13.51 \| 368.51%
74	RPL32 \| E4_Da \| 12.88 \| 60.20%	FAU \| E3_Ab \| 13.04 \| 108.63%	UBC \| E2_Al \| 12.96 \| 42.88%	RPL23 \| E6_Da \| 13.65 \| 46.94%	HSP90AB3P \| E1_Da \| 13.64 \| 88908.31%	FAU \| E3_Ab \| 13.50 \| 62.86%
75	BX323046.3 \| E1_Da \| 12.85 \| 72723.29%	AC096506.5 \| E1_Da \| 12.99 \| 1272687.98%	PKM2 \| E6_Ab \| 12.95 \| 71.83%	AC110814.2 \| E1_Ab \| 13.63 \| 495646.73%	DBI \| E1_Ac \| 13.64 \| 510.19%	ATP5E \| E1_Ac \| 13.47 \| 619.50%
76	CALM2 \| E7_Da \| 12.85 \| 103.55%	HNRPA2B1 \| E6_Da \| 12.99 \| 166.99%	PTMA \| E6_Ac \| 12.94 \| 39.22%	EIF4G3 \| E4_Aa \| 13.63 \| 8144.07%	HLA-DPA1 \| E4_Ab \| 13.63 \| 120.78%	AC104581.22 \| E2_Aa \| 13.45 \| 120412.02%
77	AL355076.5 \| E3_Aa \| 12.81 \| 121337.38%	TUBA1C \| E5_Da \| 12.96 \| 411.84%	FAU \| E3_Ab \| 12.93 \| 104.66%	DBI \| E1_Ac \| 13.61 \| 418.60%	PTMA \| E6_Ac \| 13.63 \| 70.01%	DBI \| E1_Ac \| 13.45 \| 368.13%
78	AC016734.7 \| E2_Aa \| 12.81 \| 172141.40%	HSP90AB3P \| E2_Da \| 12.95 \| 70072.40%	AC006226.4 \| E3_Da \| 12.92 \| 57269.33%	AC004833.1 \| E2_Da \| 13.59 \| 25653.12%	HLA-A \| E4_Da \| 13.62 \| 273.83%	UBC \| E2_Ah \| 13.44 \| 49.64%
79	HSPA8 \| E7_Da \| 12.80 \| 50.66%	ATP5E \| E1_Ac \| 12.94 \| 988.69%	AC016734.7 \| E2_Aa \| 12.92 \| 884799.49%	AP000688.1 \| E2_Aa \| 13.58 \| 604153.67%	GAPDH \| E2_Ac \| 13.62 \| 20.19%	RPS21 \| E3_Dd \| 13.39 \| 191.26%
80	ARPC5 \| E1_Ac \| 12.80 \| 164.34%	DBI \| E1_Ac \| 12.89 \| 369.11%	YBX1 \| E5_Da \| 12.92 \| 113.67%	TUBA1C \| E5_Ac \| 13.58 \| 413.30%	AFMID \| E12_Db \| 13.61 \| 4655.55%	UBC \| E2_Al \| 13.39 \| 47.93%
81	HSPA8 \| E9_Ab \| 12.78 \| 49.84%	AC009121.8 \| E2_Da \| 12.89 \| 224644.53%	HSPA8 \| E9_Ab \| 12.91 \| 36.59%	EIF5A \| E8_Da \| 13.57 \| 112.84%	TEX11 \| E3_Aa \| 13.61 \| 1545274.21%	TOMM7 \| E1_Ab \| 13.39 \| 256.05%
82	RP11-753C18.4 \| E1_Da \| 12.77 \| 308665.23%	PTMA \| E4_Db \| 12.89 \| 39.97%	PCNA \| E2_Ab \| 12.87 \| 158.73%	CACNB2 \| E21_Dd \| 13.57 \| 126317.27%	AP002364.4 \| E1_Da \| 13.59 \| 74099.78%	AL354710.17 \| E2_Da \| 13.39 \| 95980.53%
83	RPL36 \| E2_Ab \| 12.77 \| 42.28%	UBC \| E2_Ah \| 12.88 \| 49.17%	AC011737.10 \| E1_Da \| 12.87 \| 33014.70%	TOMM7 \| E1_Ab \| 13.55 \| 382.95%	EEF1B2 \| E1_Ad \| 13.57 \| 337.16%	HLA-DPA1 \| E4_Ab \| 13.38 \| 74.59%
84	HNRNPC \| E3_Ab \| 12.67 \| 223.21%	HSP90AB1 \| E11_Db \| 12.88 \| 54.16%	STMN1 \| E6_Db \| 12.86 \| 295.19%	NANOGP1 \| E4_Aa \| 13.54 \| 117868.05%	UBC \| E2_Dm \| 13.56 \| 42.88%	AFMID \| E12_Db \| 13.38 \| 3316.73%
85	AC110814.2 \| E1_Ab \| 12.64 \| 98118.71%	HMGB1L15 \| E1_Da \| 12.87 \| 1116.55%	PTMA \| E4_Db \| 12.86 \| 37.03%	AL139260.19 \| E2_Aa \| 13.54 \| 208364.89%	AC011740.7 \| E4_Aa \| 13.56 \| 28172.68%	HLA-DMA \| E1_Ac \| 13.37 \| 97.20%
86	AC004448.3 \| E1_Da \| 12.64 \| 420.66%	UBC \| E2_Al \| 12.86 \| 48.55%	DBI \| E1_Ac \| 12.85 \| 323.72%	RPL32 \| E4_Da \| 13.53 \| 99.88%	NME1-NME2 \| E10_Ab \| 13.54 \| 474.83%	AL589843.9 \| E3_Da \| 13.36 \| 49516.61%
87	HLA-DQA1 \| E4_Db \| 12.63 \| 55.78%	EEF1A1 \| E9_Ab \| 12.86 \| 28.79%	RPL13A \| E9_Da \| 12.85 \| 38.89%	FAU \| E3_Ab \| 13.52 \| 62.77%	UBC \| E2_Ag \| 13.54 \| 42.15%	AC011740.7 \| E4_Aa \| 13.30 \| 21371.69%
88	RPL19 \| E3_Da \| 12.63 \| 28.44%	AC006226.4 \| E3_Da \| 12.86 \| 127749.72%	AC092268.4 \| E2_Aa \| 12.85 \| 19485.57%	TPI1 \| E7_Ab \| 13.51 \| 158.41%	AL589843.9 \| E3_Da \| 13.54 \| 76994.88%	AC092268.4 \| E2_Db \| 13.30 \| 9407.00%
89	AL109615.42 \| E2_Aa \| 12.62 \| 194188.82%	YWHAZ \| E11_Dc \| 12.85 \| 115.71%	HMGB1L15 \| E1_Ac \| 12.83 \| 1328.88%	HLA-DMA \| E1_Ac \| 13.51 \| 95.52%	EIF4G3 \| E4_Aa \| 13.53 \| 5460.12%	DENND1B \| E4_Aa \| 13.29 \| 38000.12%
90	HSPA8 \| E9_Da \| 12.62 \| 44.67%	STMN1 \| E6_Db \| 12.83 \| 269.85%	NME1-NME2 \| E10_Ab \| 12.81 \| 345.23%	RPS21 \| E3_Dd \| 13.50 \| 211.78%	AC092268.4 \| E2_Aa \| 13.53 \| 19663.32%	PKM2 \| E6_Ab \| 13.28 \| 62.38%
91	AL121893.21 \| E1_Da \| 12.61 \| 64451.67%	AC011737.10 \| E1_Da \| 12.81 \| 56443.42%	ZNF695 \| E4_Dc \| 12.78 \| 22301.58%	CSF2RA \| E14_Da \| 13.49 \| 265028.58%	CACNB2 \| E21_Dd \| 13.52 \| 161067.34%	CACNB2 \| E21_Dd \| 13.27 \| 102430.82%
92	PKM2 \| E6_Ab \| 12.60 \| 86.32%	RAN \| E1_Ab \| 12.79 \| 164.75%	C6orf48 \| E2_Ae \| 12.77 \| 494.71%	AC092671.2 \| E3_Aa \| 13.47 \| 16767.21%	HSPA8 \| E9_Da \| 13.49 \| 39.71%	TPT1 \| E1_Ad \| 13.26 \| 42.17%
93	HMGN1 \| E7_Da \| 12.59 \| 78.12%	AP002364.4 \| E1_Da \| 12.79 \| 19006.46%	HSP90AB3P \| E1_Da \| 12.76 \| 40119.72%	BRCA1 \| E14_Da \| 13.46 \| 10225.43%	ATP5E \| E1_Ac \| 13.48 \| 726.98%	EIF4G3 \| E4_Aa \| 13.26 \| 3149.17%
94	RPL23 \| E6_Da \| 12.58 \| 26.93%	HMGA1 \| E7_Da \| 12.78 \| 101.26%	UBC \| E2_De \| 12.75 \| 37.00%	CCDC149 \| E8_Aa \| 13.44 \| 382582.66%	RPL13A \| E9_Da \| 13.46 \| 34.87%	LDHB \| E1_Ab \| 13.24 \| 236.75%
95	NME1-NME2 \| E10_Ab \| 12.56 \| 303.17%	RP11-753C18.4 \| E1_Da \| 12.77 \| 231371.12%	PTMA \| E7_Da \| 12.75 \| 34.26%	AC011737.10 \| E1_Da \| 13.43 \| 61966.44%	HLA-DMA \| E1_Ac \| 13.44 \| 127.59%	ACTA1 \| E3_Ab \| 13.23 \| 89248.54%
96	WIPF1 \| E11_Db \| 12.56 \| 266.06%	ZNF695 \| E4_Dc \| 12.71 \| 20499.20%	LDHA \| E8_Ab \| 12.73 \| 77.29%	AL354710.17 \| E1_Da \| 13.43 \| 113581.36%	AL139260.19 \| E2_Aa \| 13.44 \| 331291.78%	UBC \| E2_De \| 13.22 \| 42.68%
97	AC104581.22 \| E2_Aa \| 12.55 \| 24197.59%	HLA-DMA \| E1_Ac \| 12.70 \| 98.64%	RPS21 \| E2_Ac \| 12.72 \| 412.35%	AL136219.17 \| E2_Aa \| 13.43 \| 5070.39%	PKM2 \| E2_Da \| 13.43 \| 86.32%	EEF1B2 \| E1_Ad \| 13.21 \| 178.49%
98	EIF4G3 \| E4_Aa \| 12.53 \| 1479.49%	RAC2 \| E8_Da \| 12.70 \| 118.51%	FCRLA \| E1_Ab \| 12.71 \| 281.64%	YBX1 \| E5_Da \| 13.42 \| 130.43%	RPL36 \| E2_Ab \| 13.42 \| 59.86%	EFHB \| E12_Da \| 13.20 \| 226305.38%
99	DBI \| E1_Ac \| 12.53 \| 275.30%	HNRNPD \| E1_Ab \| 12.69 \| 159.60%	AP002364.4 \| E1_Da \| 12.71 \| 24399.62%	HSP90AB1 \| E11_Db \| 13.39 \| 79.13%	HMGA1 \| E7_Da \| 13.42 \| 102.85%	AC110814.2 \| E1_Ab \| 13.19 \| 237258.71%
100	AL109615.42 \| E1_Da \| 12.52 \| 180658.99%	HSP90AB3P \| E1_Da \| 12.68 \| 58199.70%	LDHA \| E8_Da \| 12.70 \| 75.77%	NSMCE4A \| E7_Da \| 13.38 \| 3274.81%	CSF2RA \| E14_Da \| 13.40 \| 194355.47%	HMGA1 \| E7_Da \| 13.18 \| 81.15%
101	BRCA1 \| E14_Da \| 12.48 \| 7135.89%	AC025264.16 \| E4_Aa \| 12.63 \| 191382.12%	PKM2 \| E1_Ab \| 12.67 \| 59.08%	EEF1B2 \| E1_Ad \| 13.35 \| 227.32%	EFHB \| E12_Da \| 13.40 \| 324518.32%	TEX11 \| E3_Aa \| 13.16 \| 553461.22%
102	AL359851.19 \| E3_Aa \| 12.47 \| 336434.07%	PTMA \| E5_Da \| 12.63 \| 33.37%	HLA-A \| E4_Da \| 12.67 \| 282.20%	C1RL \| E6_Ab \| 13.35 \| 24312.74%	AC092671.2 \| E3_Aa \| 13.38 \| 27314.56%	AL139260.19 \| E2_Aa \| 13.15 \| 171360.44%
103	CACNB2 \| E21_Dd \| 12.47 \| 52712.44%	PTMA \| E7_Da \| 12.61 \| 32.99%	HMGB1 \| E8_Db \| 12.65 \| 145.88%	TPT1 \| E1_Ad \| 13.35 \| 61.04%	AC105935.2 \| E2_Aa \| 13.37 \| 22130.96%	NANOGP1 \| E4_Aa \| 13.14 \| 89416.32%
104	AC090680.11 \| E5_Aa \| 12.46 \| 154907.05%	YBX1 \| E5_Da \| 12.60 \| 94.83%	HSP90AB1 \| E13_Ab \| 12.65 \| 39.71%	STMN1 \| E6_Db \| 13.33 \| 321.14%	AC022443.5 \| E2_Aa \| 13.34 \| 89463.45%	YBX1 \| E5_Da \| 13.14 \| 112.54%
105	HLA-DQB1 \| E9_Db \| 12.46 \| 48.20%	LDHA \| E8_Ab \| 12.58 \| 85.23%	WIPF1 \| E11_Db \| 12.64 \| 177.32%	TEX11 \| E3_Aa \| 13.32 \| 806465.78%	HSP90AA4P \| E4_Aa \| 13.34 \| 594438.95%	CSF2RA \| E14_Da \| 13.13 \| 17448.23%
106	PTMA \| E2_Ae \| 12.45 \| 48.40%	AC068538.8 \| E2_Aa \| 12.56 \| 132260.08%	AC006226.4 \| E3_Aa \| 12.60 \| 45622.65%	AC092268.4 \| E1_Da \| 13.32 \| 5436.18%	AMBRA1 \| E9_Da \| 13.32 \| 6181.40%	AC092671.2 \| E3_Aa \| 13.13 \| 17158.19%
107	HLA-DPB1 \| E4_Ab \| 12.45 \| 29.09%	TPM3 \| E3_Af \| 12.55 \| 546.30%	UBC \| E2_Ag \| 12.59 \| 33.20%	PKM2 \| E6_Ab \| 13.32 \| 57.04%	PKM2 \| E6_Ab \| 13.29 \| 78.73%	TUBA1C \| E5_Ac \| 13.13 \| 335.52%
108	PSAP \| E15_Dc \| 12.44 \| 67.04%	PTMA \| E4_Ab \| 12.55 \| 31.69%	HNRNPH1 \| E1_Da \| 12.59 \| 145.46%	HMGA1 \| E7_Da \| 13.31 \| 77.87%	NANOGP1 \| E4_Aa \| 13.29 \| 126064.40%	HSP90AB3P \| E1_Da \| 13.09 \| 52316.09%
109	RPL15 \| E4_Da \| 12.43 \| 67.96%	UBC \| E2_De \| 12.54 \| 38.98%	IGHA2 \| E3_Db \| 12.57 \| 164.99%	AL121893.21 \| E1_Da \| 13.30 \| 56449.11%	IGHG4 \| E1_Da \| 13.28 \| 1424.61%	AC005000.2 \| E1_Da \| 13.07 \| 261.75%
110	ACTA1 \| E3_Ab \| 12.43 \| 81673.35%	RPS27A \| E6_Da \| 12.52 \| 50.88%	ATP5E \| E1_Ac \| 12.56 \| 680.61%	HMGB1L15 \| E1_Ac \| 13.30 \| 1022.43%	RPS29 \| E3_Da \| 13.27 \| 52.05%	UBC \| E2_Ag \| 13.05 \| 37.87%
111	AFMID \| E12_Db \| 12.40 \| 2236.89%	AC005000.2 \| E1_Da \| 12.52 \| 153.51%	AL354710.17 \| E2_Da \| 12.55 \| 87749.05%	AC011444.5 \| E3_Aa \| 13.29 \| 58119.81%	ARPC5 \| E1_Ac \| 13.27 \| 574.56%	CCDC149 \| E8_Aa \| 13.01 \| 41503.83%
112	NANOGP1 \| E4_Aa \| 12.39 \| 74323.60%	GDI2 \| E8_Da \| 12.51 \| 93.56%	YWHAZ \| E11_Dc \| 12.55 \| 111.50%	HSP90AB3P \| E3_Da \| 13.29 \| 54519.11%	AC016734.7 \| E2_Aa \| 13.25 \| 1112754.70%	AL136219.17 \| E2_Aa \| 13.00 \| 3303.42%
113	AC008629.7 \| E1_Da \| 12.38 \| 17900.67%	CALM2 \| E7_Da \| 12.50 \| 101.95%	AL121759.25 \| E2_Aa \| 12.54 \| 62047.76%	AC004448.3 \| E2_Aa \| 13.28 \| 3691.44%	AC110814.2 \| E1_Ab \| 13.24 \| 367809.76%	BRCA1 \| E14_Da \| 12.99 \| 4528.64%
114	H3F3A \| E5_Da \| 12.38 \| 1550.21%	AL354710.17 \| E1_Da \| 12.49 \| 73360.53%	AC110814.2 \| E1_Ab \| 12.53 \| 231465.23%	PTMA \| E5_Da \| 13.28 \| 38.93%	AL354710.17 \| E3_Aa \| 13.24 \| 163698.64%	RPL32 \| E4_Da \| 12.98 \| 72.02%
115	AL589843.9 \| E3_Da \| 12.38 \| 42326.19%	AC006226.4 \| E3_Aa \| 12.48 \| 98127.65%	BRCA1 \| E14_Da \| 12.51 \| 2067.82%	NEXN \| E10_Da \| 13.28 \| 1102456.23%	AL121893.21 \| E1_Da \| 13.22 \| 172732.38%	TPT1 \| E5_Da \| 12.97 \| 34.40%
116	HMGA1 \| E6_Ab \| 12.38 \| 113.74%	ACTA1 \| E3_Ab \| 12.47 \| 107847.06%	HMGB1L15 \| E1_Da \| 12.49 \| 1049.61%	RUNDC2C \| E5_Aa \| 13.26 \| 7840.12%	AC012652.1 \| E7_Ab \| 13.20 \| 2393.38%	PKM2 \| E2_Da \| 12.97 \| 50.32%
117	AP001605.1 \| E2_Aa \| 12.38 \| 12953.21%	TUBA1C \| E5_Ac \| 12.47 \| 293.43%	AC104581.22 \| E2_Aa \| 12.49 \| 103997.19%	RPL19 \| E3_Da \| 13.26 \| 28.45%	RPS3 \| E3_Aa \| 13.19 \| 30.58%	AMBRA1 \| E9_Da \| 12.96 \| 4977.51%
118	HIST1H2BK \| E1_Ab \| 12.37 \| 192.01%	OAZ1 \| E3_Aa \| 12.47 \| 42.86%	HSP90AA4P \| E4_Aa \| 12.48 \| 151152.10%	LZTS2 \| E4_Aa \| 13.25 \| 40109.18%	AC005000.2 \| E1_Da \| 13.18 \| 497.27%	RPL19 \| E3_Da \| 12.96 \| 25.22%
119	AC126474.6 \| E3_Aa \| 12.36 \| 31217.94%	HLA-DPA1 \| E6_Da \| 12.46 \| 52.37%	AL121893.21 \| E2_Aa \| 12.48 \| 63925.33%	STMN1 \| E6_Ac \| 13.25 \| 304.20%	C6orf48 \| E2_Ae \| 13.18 \| 460.95%	AL354710.17 \| E3_Aa \| 12.95 \| 71150.39%
120	LDHB \| E1_Ab \| 12.34 \| 173.10%	STMN1 \| E6_Ac \| 12.44 \| 206.35%	CACNB2 \| E21_Dd \| 12.47 \| 81799.26%	CC2D1A \| E24_Aa \| 13.24 \| 6218.46%	TPT1 \| E1_Ad \| 13.18 \| 69.56%	AL121893.21 \| E1_Da \| 12.95 \| 65115.57%
121	HSP90AB3P \| E3_Da \| 12.31 \| 117239.00%	LDHA \| E8_Da \| 12.43 \| 76.73%	STMN1 \| E6_Ac \| 12.45 \| 222.31%	AMBRA1 \| E9_Da \| 13.24 \| 9250.30%	RPL19 \| E3_Da \| 13.16 \| 38.32%	ARPC5 \| E1_Ac \| 12.95 \| 232.35%
122	ZNF253 \| E4_Da \| 12.30 \| 2710.29%	HLA-DMA \| E1_Ad \| 12.40 \| 80.56%	HMGN1 \| E7_Da \| 12.45 \| 95.27%	TMTC1 \| E6_Aa \| 13.24 \| 375807.66%	CCDC149 \| E8_Aa \| 13.14 \| 27905.45%	AC105935.2 \| E2_Aa \| 12.95 \| 15489.93%
123	CCDC149 \| E8_Aa \| 12.30 \| 77770.78%	HSP90AA4P \| E4_Aa \| 12.40 \| 279600.41%	AC010234.5 \| E4_Aa \| 12.44 \| 384005.50%	AL121759.25 \| E1_Da \| 13.23 \| 43454.90%	EEF1A1 \| E9_Ab \| 13.12 \| 52.97%	AC012652.1 \| E7_Ab \| 12.95 \| 1618.29%
124	AC008279.3 \| E5_Da \| 12.29 \| 263582.40%	RPL23 \| E6_Da \| 12.40 \| 31.50%	HNRNPC \| E3_Ab \| 12.43 \| 116.67%	RPS8 \| E3_Da \| 13.22 \| 21.35%	AL136219.17 \| E2_Aa \| 13.12 \| 3874.93%	IGHA1 \| E2_Aa \| 12.94 \| 27.23%
125	AL161742.7 \| E2_Aa \| 12.28 \| 501689.59%	HMGB1 \| E8_Dc \| 12.39 \| 118.27%	AFMID \| E12_Db \| 12.43 \| 1782.79%	HLA-DQA1 \| E4_Ad \| 13.22 \| 96.59%	GSN \| E6_Aa \| 13.11 \| 5067.46%	AC022443.5 \| E2_Aa \| 12.93 \| 21454.99%
126	AC078872.13 \| E2_Aa \| 12.26 \| 104300.34%	PTMA \| E2_Ae \| 12.36 \| 27.77%	AL589843.9 \| E3_Da \| 12.42 \| 22306.57%	AC012652.1 \| E7_Ab \| 13.21 \| 1923.64%	LZTS2 \| E4_Aa \| 13.11 \| 30526.69%	H3F3A \| E5_Da \| 12.93 \| 2428.57%
127	AC092671.2 \| E3_Aa \| 12.24 \| 15372.68%	ATPIF1 \| E1_Ab \| 12.35 \| 167.86%	RAN \| E1_Ab \| 12.42 \| 113.71%	AL354710.17 \| E3_Aa \| 13.21 \| 97624.09%	YBX1 \| E5_Da \| 13.10 \| 149.37%	EIF5A \| E8_Da \| 12.92 \| 97.67%
128	AC011740.7 \| E4_Aa \| 12.22 \| 20916.01%	UBC \| E2_Ag \| 12.33 \| 33.65%	CALM2 \| E7_Da \| 12.42 \| 83.83%	HLA-DPA1 \| E4_Ab \| 13.21 \| 96.89%	TUBA1C \| E5_Ac \| 13.09 \| 350.78%	HNRNPC \| E3_Ab \| 12.90 \| 136.40%
129	PSAP \| E11_Ab \| 12.19 \| 56.31%	HLA-DPB1 \| E6_Ac \| 12.32 \| 93.48%	NANOGP1 \| E4_Aa \| 12.41 \| 65416.12%	HLA-DPB1 \| E6_Ac \| 13.21 \| 90.81%	TMTC1 \| E6_Aa \| 13.09 \| 374768.72%	EEF1A1 \| E9_Db \| 12.90 \| 27.25%
130	HLA-DMA \| E1_Ad \| 12.16 \| 70.67%	RPL32 \| E4_Da \| 12.31 \| 103.21%	RPL32 \| E4_Da \| 12.37 \| 122.91%	C17orf87 \| E5_Da \| 13.20 \| 2145.92%	AL080243.21 \| E3_Da \| 13.09 \| 85173.35%	LZTS2 \| E4_Aa \| 12.90 \| 18767.45%
131	AL136219.17 \| E2_Aa \| 12.15 \| 3347.94%	C6orf48 \| E2_Ae \| 12.31 \| 470.38%	PTMA \| E2_Ae \| 12.37 \| 26.36%	AC005197.1 \| E1_Da \| 13.19 \| 38469.46%	HMGA1 \| E6_Ab \| 13.08 \| 81.13%	TMTC1 \| E6_Aa \| 12.89 \| 145582.90%
132	HNRPA2B1 \| E6_Da \| 12.14 \| 110.00%	HMGB1 \| E8_Db \| 12.30 \| 110.95%	ZFP36L1 \| E2_Da \| 12.36 \| 130.95%	GSN \| E6_Aa \| 13.19 \| 6139.80%	RBM39 \| E1_Af \| 13.07 \| 670.26%	RPL23 \| E6_Da \| 12.88 \| 28.41%
133	AC092268.4 \| E2_Ab \| 12.13 \| 9535.41%	TPI1 \| E7_Ab \| 12.30 \| 124.36%	TUBA1C \| E5_Ac \| 12.35 \| 274.26%	LDHB \| E1_Ab \| 13.18 \| 234.76%	AC005197.1 \| E1_Da \| 13.07 \| 16107.14%	AC073852.4 \| E1_Da \| 12.88 \| 854610.64%
134	HLA-DMA \| E4_Ab \| 12.12 \| 68.96%	BX323046.3 \| E1_Da \| 12.29 \| 75057.38%	PCNA \| E5_Da \| 12.34 \| 110.38%	ST3GAL5 \| E11_Aa \| 13.17 \| 16346.91%	KLK7 \| E7_Da \| 13.07 \| 86118.69%	NME1-NME2 \| E10_Ab \| 12.88 \| 264.87%
135	HLA-DPA1 \| E6_Da \| 12.11 \| 22.75%	HMGB1L15 \| E1_Db \| 12.28 \| 742.61%	UBC \| E2_Dm \| 12.30 \| 27.14%	KLK7 \| E7_Da \| 13.16 \| 83217.78%	NEXN \| E10_Da \| 13.07 \| 1392159.33%	GSN \| E6_Aa \| 12.87 \| 2502.03%
136	PKM2 \| E1_Ab \| 12.11 \| 61.50%	AC008629.7 \| E1_Da \| 12.28 \| 18671.45%	CD52 \| E2_Aa \| 12.30 \| 58.90%	HSP90AB1 \| E13_Da \| 13.16 \| 67.60%	AL671277.5 \| E8_Da \| 13.06 \| 18563.29%	NSMCE4A \| E7_Da \| 12.87 \| 1943.77%
137	AC011825.13 \| E2_Da \| 12.10 \| 291970.79%	IER2 \| E2_Ab \| 12.27 \| 294.27%	AL136219.17 \| E2_Aa \| 12.28 \| 2460.51%	AC005000.2 \| E1_Da \| 13.16 \| 373.87%	AC022443.5 \| E1_Da \| 13.06 \| 73462.09%	PTMA \| E7_Dd \| 12.86 \| 31.70%
138	PTMA \| E7_Da \| 12.10 \| 38.01%	HMGN1 \| E7_Da \| 12.26 \| 86.18%	HMGB1L15 \| E1_Db \| 12.27 \| 898.83%	AC105935.2 \| E2_Aa \| 13.15 \| 15447.46%	LDHB \| E1_Ab \| 13.05 \| 345.84%	HMGB1L15 \| E1_Ac \| 12.86 \| 902.05%
139	UBC \| E2_Al \| 12.06 \| 52.82%	ZFP36L1 \| E2_Da \| 12.25 \| 120.85%	HLA-DPB1 \| E6_Ac \| 12.27 \| 81.74%	H3F3A \| E5_Da \| 13.15 \| 3814.98%	ZFP36L1 \| E2_Da \| 13.05 \| 164.92%	AC004833.1 \| E2_Da \| 12.86 \| 19520.75%
140	FCRLA \| E1_Ab \| 12.06 \| 215.27%	RPS21 \| E3_Dd \| 12.20 \| 138.58%	WIPF1 \| E4_Ac \| 12.26 \| 136.57%	AL161742.7 \| E2_Aa \| 13.14 \| 215552.93%	CCT3 \| E7_Da \| 13.03 \| 371.96%	STMN1 \| E6_Db \| 12.86 \| 283.12%
141	AC021078.5 \| E3_Aa \| 12.05 \| 76565.36%	YBX1 \| E7_Db \| 12.20 \| 71.88%	ISG20 \| E1_Ab \| 12.26 \| 557.20%	AC126474.6 \| E3_Aa \| 13.13 \| 67045.20%	AL355076.5 \| E3_Aa \| 13.03 \| 330713.29%	C1RL \| E6_Ab \| 12.85 \| 10443.61%
142	PRPF18 \| E3_Aa \| 12.05 \| 2277.16%	HSP90AA4P \| E1_Da \| 12.19 \| 241925.84%	RPL19 \| E3_Da \| 12.25 \| 27.54%	HMGB1 \| E8_Db \| 13.12 \| 310.26%	AC011444.5 \| E3_Aa \| 13.03 \| 308848.63%	AC011444.5 \| E3_Aa \| 12.84 \| 79224.91%
143	UBL5 \| E1_Ab \| 12.05 \| 140.17%	EEF1B2 \| E1_Ad \| 12.19 \| 135.02%	TPI1 \| E7_Ab \| 12.25 \| 113.50%	TPT1 \| E5_Da \| 13.11 \| 51.97%	RPL37 \| E2_Ab \| 12.97 \| 6609.60%	RPL5 \| E1_Ab \| 12.84 \| 29.30%
144	TEX11 \| E3_Aa \| 12.05 \| 111283.50%	AL080243.21 \| E4_Aa \| 12.18 \| 28781.60%	TAGLN2 \| E7_Da \| 12.24 \| 92.78%	CCT3 \| E7_Da \| 13.11 \| 406.19%	AC025264.16 \| E4_Aa \| 12.96 \| 221901.96%	AC005197.1 \| E1_Da \| 12.82 \| 15504.15%
145	NSMCE4A \| E7_Da \| 12.04 \| 1034.96%	PKM2 \| E2_Da \| 12.17 \| 35.03%	TPM3 \| E3_Af \| 12.24 \| 514.31%	ACTA1 \| E3_Ab \| 13.08 \| 61555.97%	AL671277.5 \| E10_Aa \| 12.95 \| 17223.54%	C6orf48 \| E2_Ae \| 12.82 \| 376.87%
146	CSF2RA \| E14_Da \| 12.04 \| 1941.90%	AL589843.9 \| E3_Da \| 12.16 \| 72411.02%	RAC2 \| E8_Da \| 12.24 \| 102.14%	AC022443.5 \| E2_Aa \| 13.07 \| 15615.53%	C1RL \| E6_Ab \| 12.94 \| 17623.73%	HLA-A \| E4_Da \| 12.82 \| 131.73%
147	YBX1 \| E7_Db \| 12.04 \| 88.04%	PKM2 \| E1_Ab \| 12.16 \| 34.75%	ACTA1 \| E3_Ab \| 12.23 \| 46342.89%	PTMA \| E2_Ae \| 13.06 \| 33.43%	NSMCE4A \| E7_Da \| 12.93 \| 3025.44%	KLK7 \| E7_Da \| 12.80 \| 66958.99%
148	AMBRA1 \| E9_Da \| 12.01 \| 4373.13%	TAGLN2 \| E7_Da \| 12.15 \| 96.41%	HMGA1 \| E7_Da \| 12.23 \| 68.76%	UBC \| E2_Ac \| 13.05 \| 56.87%	ST3GAL5 \| E11_Aa \| 12.92 \| 16877.94%	HSP90AA4P \| E4_Aa \| 12.80 \| 275840.43%
149	XXyac-R12DG2.2 \| E2_Aa \| 12.01 \| 6136.72%	AC096506.5 \| E2_Aa \| 12.15 \| 707329.90%	RPL23 \| E6_Da \| 12.23 \| 36.41%	HMGB1L15 \| E1_Da \| 13.04 \| 855.65%	ATPIF1 \| E1_Ab \| 12.92 \| 196.68%	ZFP36L1 \| E2_Da \| 12.80 \| 156.73%
150	PTMA \| E4_Db \| 12.00 \| 35.51%	COPEB \| E1_Ab \| 12.14 \| 103.10%	CCDC149 \| E8_Aa \| 12.23 \| 52180.13%	AC008279.3 \| E5_Da \| 13.03 \| 201607.55%	AC006226.4 \| E3_Da \| 12.90 \| 212269.97%	NEXN \| E10_Da \| 12.80 \| 161744.52%
151	RAC2 \| E8_Da \| 11.99 \| 86.22%	AD000092.1 \| E2_Aa \| 12.12 \| 36823.36%	AC092671.2 \| E3_Aa \| 12.22 \| 11883.53%	UBC \| E2_Al \| 12.99 \| 54.37%	CC2D1A \| E24_Aa \| 12.90 \| 3443.72%	CCT3 \| E7_Da \| 12.79 \| 289.79%
152	AC012652.1 \| E7_Ab \| 11.99 \| 1199.18%	WIPF1 \| E11_Db \| 12.12 \| 150.60%	EEF1B2 \| E1_Ad \| 12.22 \| 149.29%	PTMA \| E7_Da \| 12.98 \| 31.78%	ABHD14A \| E4_Aa \| 12.89 \| 8163.47%	TPI1 \| E7_Ab \| 12.78 \| 116.46%
153	AC013752.10 \| E4_Da \| 11.99 \| 41246.01%	AC004448.3 \| E2_Aa \| 12.09 \| 5174.91%	HNRPA2B1 \| E9_Ab \| 12.22 \| 72.80%	YBX1 \| E7_Db \| 12.98 \| 96.22%	AC145423.8 \| E5_Aa \| 12.89 \| 6509.63%	HNRPA2B1 \| E6_Da \| 12.78 \| 125.22%
154	GSN \| E6_Aa \| 11.98 \| 675.65%	RBM3 \| E7_Db \| 12.07 \| 185.42%	HSP90AA4P \| E1_Da \| 12.22 \| 125789.98%	AC126474.6 \| E2_Da \| 12.97 \| 59870.74%	CXorf56 \| E7_Ab \| 12.88 \| 3794.40%	AL354710.17 \| E1_Da \| 12.78 \| 63227.26%
155	TMTC1 \| E6_Aa \| 11.98 \| 28196.76%	ELF1 \| E5_Da \| 12.06 \| 70.52%	AC025264.16 \| E4_Aa \| 12.21 \| 102577.05%	AC145423.8 \| E5_Aa \| 12.95 \| 5697.40%	AC021078.5 \| E3_Aa \| 12.87 \| 61167.29%	PTMA \| E7_Da \| 12.78 \| 29.93%
156	EFHB \| E12_Da \| 11.98 \| 110547.02%	ZNF253 \| E4_Da \| 12.05 \| 3099.61%	RPL15 \| E2_Ab \| 12.21 \| 90.71%	HLA-DPB1 \| E6_Ab \| 12.95 \| 76.19%	AL161742.7 \| E2_Aa \| 12.86 \| 938031.32%	UBC \| E2_Dm \| 12.78 \| 31.40%
157	UBC \| E2_Ac \| 11.97 \| 49.59%	RPL18A \| E3_Aa \| 12.04 \| 44.33%	LDHA \| E6_Da \| 12.20 \| 53.62%	PTMA \| E7_Dd \| 12.94 \| 30.94%	HSPA1A \| E1_Da \| 12.86 \| 168.40%	AC025264.16 \| E4_Aa \| 12.77 \| 113232.58%
158	AL139260.19 \| E2_Aa \| 11.96 \| 65482.85%	HLA-DPB1 \| E6_Ab \| 12.03 \| 76.49%	EEF1A1 \| E9_Ab \| 12.20 \| 25.23%	CXorf56 \| E7_Ab \| 12.94 \| 3386.04%	HSP90AA4P \| E1_Da \| 12.85 \| 424462.46%	HSP90AB3P \| E3_Aa \| 12.77 \| 41863.67%
159	HMGA1 \| E7_Da \| 11.96 \| 85.10%	AL354710.17 \| E2_Da \| 12.02 \| 53147.71%	TOMM7 \| E1_Ab \| 12.19 \| 331.36%	THEM5 \| E6_Da \| 12.94 \| 47839.59%	EIF5A \| E8_Da \| 12.83 \| 108.95%	ST3GAL5 \| E11_Aa \| 12.75 \| 6336.50%
160	AC005000.2 \| E1_Da \| 11.96 \| 129.72%	ARF1 \| E1_Ab \| 12.02 \| 133.80%	AC012652.1 \| E7_Ab \| 12.18 \| 1300.33%	RAC2 \| E8_Da \| 12.92 \| 110.40%	AC008481.9 \| E1_Da \| 12.83 \| 231752.78%	AL161742.7 \| E2_Aa \| 12.73 \| 288259.25%
161	ST3GAL5 \| E11_Aa \| 11.95 \| 1432.78%	RPL15 \| E4_Da \| 12.00 \| 57.79%	AC011740.7 \| E4_Aa \| 12.17 \| 15119.01%	HEATR3 \| E15_Ab \| 12.92 \| 11675.63%	HEATR3 \| E15_Ab \| 12.82 \| 10282.13%	RAN \| E1_Ab \| 12.72 \| 132.88%
162	TUBA1C \| E5_Da \| 11.95 \| 464.06%	EIF4G2 \| E21_Db \| 12.00 \| 59.05%	EIF4G2 \| E21_Db \| 12.17 \| 62.02%	AC008481.9 \| E1_Da \| 12.91 \| 184406.50%	RPS8 \| E3_Da \| 12.81 \| 25.56%	STMN1 \| E6_Ac \| 12.72 \| 258.16%
163	UBC \| E2_Ah \| 11.95 \| 48.79%	AC104581.22 \| E2_Aa \| 12.00 \| 97077.38%	YBX1 \| E7_Db \| 12.16 \| 67.35%	UBC \| E2_Ah \| 12.91 \| 51.48%	HSP90AB1 \| E13_Ac \| 12.81 \| 36.60%	CC2D1A \| E24_Aa \| 12.72 \| 3261.21%
164	CAP1 \| E14_Db \| 11.93 \| 91.13%	HNRNPC \| E3_Da \| 11.99 \| 86.94%	TPM4 \| E11_Aa \| 12.16 \| 121.02%	AC106827.2 \| E1_Da \| 12.89 \| 8157.20%	HSP90AA6P \| E1_Da \| 12.80 \| 1086306.17%	HLA-DPB1 \| E6_Ac \| 12.72 \| 59.13%
165	CCT3 \| E7_Da \| 11.93 \| 271.05%	GNAS \| E4_Dc \| 11.99 \| 975.98%	TMTC1 \| E6_Aa \| 12.16 \| 351912.82%	NUP43 \| E8_Da \| 12.88 \| 3772.32%	AP000688.1 \| E2_Aa \| 12.79 \| 3121946.43%	AP000688.1 \| E2_Aa \| 12.72 \| 410421.35%
166	LDHA \| E8_Da \| 11.93 \| 87.63%	COPEB \| E2_Da \| 11.98 \| 92.10%	AC009121.8 \| E2_Da \| 12.15 \| 102836.75%	TPM4 \| E11_Aa \| 12.88 \| 273.60%	C1orf130 \| E4_Ab \| 12.79 \| 18853.89%	AC009121.8 \| E2_Da \| 12.72 \| 198911.47%
167	AC090680.11 \| E4_Da \| 11.92 \| 106288.11%	AL121759.25 \| E2_Aa \| 11.98 \| 28832.43%	IFRD1 \| E2_Ab \| 12.14 \| 436.10%	ABHD14A \| E4_Aa \| 12.87 \| 5195.12%	TAGLN2 \| E7_Da \| 12.78 \| 93.19%	FCRLA \| E1_Ab \| 12.72 \| 196.45%
168	YBX1 \| E5_Da \| 11.91 \| 80.57%	COPEB \| E2_Dc \| 11.98 \| 91.85%	AC096506.5 \| E2_Aa \| 12.12 \| 296018.16%	AC084398.25 \| E3_Aa \| 12.87 \| 460556.47%	RPL32 \| E4_Da \| 12.77 \| 81.44%	AC006226.4 \| E3_Da \| 12.71 \| 103096.85%
169	HLA-DQA1 \| E4_Ac \| 11.90 \| 33.62%	LSM7 \| E2_Aa \| 11.98 \| 368.32%	ATPIF1 \| E1_Ab \| 12.12 \| 159.27%	AC009121.8 \| E2_Da \| 12.87 \| 217114.72%	AL603832.28 \| E2_Aa \| 12.77 \| 17746.52%	AC004448.3 \| E2_Aa \| 12.68 \| 1438.78%
170	LZTS2 \| E4_Aa \| 11.90 \| 5087.78%	HLA-DMA \| E4_Ab \| 11.96 \| 59.30%	HLA-DPB1 \| E6_Ab \| 12.11 \| 73.53%	HNRPA2B1 \| E9_Ab \| 12.86 \| 150.29%	AC004833.1 \| E2_Da \| 12.77 \| 50960.32%	PTMA \| E7_De \| 12.67 \| 27.78%
171	AC096741.3 \| E4_Aa \| 11.90 \| 307460.18%	LDHA \| E6_Da \| 11.96 \| 55.35%	COPEB \| E1_Ab \| 12.11 \| 121.27%	C20orf52 \| E2_Da \| 12.86 \| 336.09%	AC092268.4 \| E2_Db \| 12.77 \| 11592.03%	RP4-552O12.1 \| E4_Da \| 12.66 \| 7910870.22%
172	AC092268.4 \| E2_Db \| 11.89 \| 8088.27%	TPT1 \| E5_Db \| 11.96 \| 20.84%	ZNF253 \| E4_Da \| 12.11 \| 3617.13%	ARPC5 \| E1_Ac \| 12.85 \| 302.89%	RAN \| E1_Ab \| 12.75 \| 189.28%	C17orf87 \| E5_Da \| 12.66 \| 974.58%
173	C6orf48 \| E2_Ae \| 11.87 \| 313.71%	TPM4 \| E10_Db \| 11.95 \| 132.75%	RBM39 \| E1_Af \| 12.10 \| 230.05%	ZFP36L1 \| E2_Da \| 12.85 \| 234.79%	COPEB \| E1_Ab \| 12.75 \| 138.01%	RUNDC2C \| E5_Aa \| 12.66 \| 4926.79%
174	RPL18A \| E3_Aa \| 11.86 \| 94.60%	AC110814.2 \| E1_Ab \| 11.93 \| 192084.21%	EIF4G3 \| E4_Aa \| 12.10 \| 1216.01%	CYB561D1 \| E2_Da \| 12.84 \| 24920.27%	AC006226.4 \| E3_Aa \| 12.74 \| 189850.96%	RAC2 \| E8_Da \| 12.65 \| 93.12%
175	RAN \| E1_Ab \| 11.85 \| 161.55%	AC005000.2 \| E2_Aa \| 11.93 \| 101.87%	POLR2J2 \| E1_Ab \| 12.09 \| 3681.68%	HNRPA2B1 \| E6_Da \| 12.84 \| 147.81%	HSP90AB3P \| E3_Aa \| 12.74 \| 47716.06%	TAGLN2 \| E7_Da \| 12.65 \| 90.45%
176	AC105935.2 \| E2_Aa \| 11.83 \| 17807.11%	CKS1B \| E1_Ac \| 11.93 \| 348.09%	TEX11 \| E3_Aa \| 12.09 \| 725054.33%	EEF1A1 \| E9_Db \| 12.83 \| 29.74%	HSP90AA4P \| E3_Aa \| 12.74 \| 392570.38%	HSP90AB1 \| E13_Da \| 12.64 \| 36.52%
177	AC096506.5 \| E1_Da \| 11.83 \| 202679.29%	CACNB2 \| E21_Dd \| 11.92 \| 155768.56%	CSF2RA \| E14_Da \| 12.08 \| 69091.78%	UBC \| E2_De \| 12.83 \| 48.85%	AC093620.6 \| E21_Da \| 12.73 \| 4667.13%	HSP90AA4P \| E3_Aa \| 12.64 \| 246144.55%
178	GDI2 \| E8_Da \| 11.83 \| 89.41%	AL355143.17 \| E2_Aa \| 11.92 \| 95562.68%	GSN \| E6_Aa \| 12.06 \| 2888.07%	NHP2L1 \| E5_Da \| 12.83 \| 376.40%	MORC2 \| E2_Da \| 12.73 \| 4655.06%	HEATR3 \| E15_Ab \| 12.63 \| 7072.48%
179	MS4A1 \| E2_Ab \| 11.83 \| 26.53%	AFMID \| E12_Db \| 11.92 \| 2485.63%	IL2RG \| E1_Ad \| 12.06 \| 256.08%	LDHA \| E8_Da \| 12.82 \| 90.64%	AC084398.25 \| E3_Aa \| 12.73 \| 489565.06%	HMGB1 \| E8_Db \| 12.62 \| 195.47%
180	C6orf170 \| E33_Da \| 11.82 \| 39967.67%	HNRPA2B1 \| E9_Ab \| 11.91 \| 79.36%	SFRS5 \| E5_Da \| 12.06 \| 93.84%	MKNK2 \| E14_Ab \| 12.81 \| 205.21%	AL138795.21 \| E5_Da \| 12.72 \| 16415.70%	AL671277.5 \| E8_Da \| 12.62 \| 10260.06%
181	HLA-A \| E4_Db \| 11.82 \| 44.56%	ACTR2 \| E11_Da \| 11.91 \| 75.50%	WIPF1 \| E3_Aa \| 12.05 \| 118.31%	HLA-DMA \| E4_Ab \| 12.81 \| 58.65%	HSP90AB1 \| E13_Da \| 12.72 \| 34.23%	HSP90AA6P \| E1_Da \| 12.62 \| 222329.96%
182	HEATR3 \| E15_Ab \| 11.82 \| 3962.72%	GNAS \| E4_Db \| 11.91 \| 922.22%	HNRNPK \| E2_Ab \| 12.05 \| 77.97%	TAGLN2 \| E7_Da \| 12.80 \| 101.71%	NUP43 \| E8_Da \| 12.68 \| 5782.89%	HMGB1L15 \| E1_Da \| 12.62 \| 762.64%
183	HMGB1L15 \| E1_Dc \| 11.81 \| 1123.77%	AC010746.8 \| E6_Aa \| 11.89 \| 153414.77%	RPS27A \| E6_Da \| 12.04 \| 46.30%	XRCC6 \| E13_Da \| 12.80 \| 191.53%	AL080243.21 \| E4_Aa \| 12.68 \| 64217.89%	AC145423.8 \| E5_Aa \| 12.62 \| 4212.47%
184	ACTR2 \| E11_Da \| 11.80 \| 92.46%	PNRC1 \| E3_Da \| 11.89 \| 119.13%	LZTS2 \| E4_Aa \| 12.04 \| 22449.76%	AC078872.13 \| E2_Aa \| 12.79 \| 120027.49%	HNRNPD \| E1_Ab \| 12.67 \| 250.69%	ATPIF1 \| E1_Ab \| 12.61 \| 158.90%
185	PTPRC \| E3_Ab \| 11.79 \| 90.51%	PCNA \| E5_Da \| 11.88 \| 87.21%	HLA-DMA \| E4_Ab \| 12.03 \| 54.12%	AC025264.16 \| E4_Aa \| 12.79 \| 71170.71%	AC009121.8 \| E2_Da \| 12.67 \| 301104.19%	CXorf56 \| E7_Ab \| 12.61 \| 2545.69%
186	EIF4G2 \| E21_Db \| 11.79 \| 64.63%	YWHAZ \| E11_Db \| 11.88 \| 58.90%	IGHG4 \| E1_Da \| 12.01 \| 776.97%	RAN \| E8_Da \| 12.77 \| 123.38%	RUNDC2C \| E5_Aa \| 12.66 \| 5396.66%	YBX1 \| E7_Db \| 12.59 \| 77.28%
187	ABHD14A \| E4_Aa \| 11.79 \| 3312.52%	ELAVL1 \| E1_Da \| 11.86 \| 794.17%	DENND1B \| E4_Aa \| 12.01 \| 15046.86%	AP002364.4 \| E2_Aa \| 12.76 \| 7809.45%	PTMA \| E7_Da \| 12.65 \| 35.49%	IGHG4 \| E1_Da \| 12.59 \| 223.27%
188	PTMA \| E6_Ac \| 11.78 \| 30.51%	TOMM7 \| E1_Ab \| 11.85 \| 319.29%	AL121759.25 \| E1_Da \| 12.01 \| 42996.38%	RAN \| E1_Ab \| 12.76 \| 122.28%	HSP90AB3P \| E2_Aa \| 12.65 \| 44666.88%	ABHD14A \| E4_Aa \| 12.58 \| 4789.20%
189	AL121893.21 \| E2_Aa \| 11.78 \| 36147.41%	RAN \| E8_Da \| 11.84 \| 85.50%	CALM2 \| E4_Da \| 11.98 \| 61.82%	UBC \| E2_Ag \| 12.76 \| 46.43%	RPL5 \| E1_Ab \| 12.62 \| 44.81%	HLA-DMA \| E1_Ad \| 12.58 \| 56.17%
190	AC013752.10 \| E3_Da \| 11.76 \| 35347.92%	AL161742.7 \| E2_Aa \| 11.84 \| 295031.58%	RPL18A \| E3_Aa \| 11.98 \| 76.60%	AD000092.1 \| E2_Aa \| 12.76 \| 34463.60%	AC112512.6 \| E2_Aa \| 12.62 \| 170974.19%	HMGB1L15 \| E1_Dc \| 12.56 \| 732.85%
191	C17orf87 \| E5_Da \| 11.75 \| 340.15%	AL354710.17 \| E3_Aa \| 11.82 \| 46171.78%	NSMCE4A \| E7_Da \| 11.97 \| 1285.55%	IGHA1 \| E2_Aa \| 12.75 \| 23.41%	ZNF833 \| E2_Da \| 12.62 \| 140529.49%	RPL36 \| E2_Ab \| 12.56 \| 35.02%
192	ARPC5 \| E4_Da \| 11.74 \| 79.27%	CALM3 \| E7_Da \| 11.82 \| 86.12%	CCT3 \| E7_Da \| 11.97 \| 202.98%	SERF2 \| E3_Af \| 12.75 \| 200.15%	C17orf87 \| E5_Da \| 12.60 \| 1514.43%	AC008481.9 \| E1_Da \| 12.55 \| 122273.18%
193	AC084398.25 \| E3_Aa \| 11.74 \| 145214.92%	NCL \| E5_Da \| 11.81 \| 64.38%	GDI2 \| E8_Da \| 11.97 \| 76.18%	PRPF18 \| E3_Da \| 12.74 \| 2748.10%	PABPC1 \| E12_Da \| 12.60 \| 35.34%	PTMA \| E5_Da \| 12.53 \| 25.12%
194	AC010234.5 \| E4_Aa \| 11.74 \| 272487.51%	HLA-A \| E4_Da \| 11.78 \| 232.07%	HEATR3 \| E15_Ab \| 11.96 \| 4860.78%	DENND1B \| E4_Aa \| 12.74 \| 39856.24%	OAZ1 \| E2_Da \| 12.60 \| 39.35%	HLA-DPB1 \| E6_Ab \| 12.53 \| 51.69%
195	TPM4 \| E10_Db \| 11.74 \| 91.17%	AC013752.10 \| E3_Da \| 11.78 \| 87700.84%	AL139260.19 \| E2_Aa \| 11.96 \| 144036.19%	AC021078.5 \| E3_Aa \| 12.74 \| 38217.86%	AP002364.4 \| E2_Aa \| 12.59 \| 37184.16%	PCNA \| E2_Ab \| 12.52 \| 175.56%
196	ARPC3 \| E2_Aa \| 11.73 \| 40.88%	TPM3 \| E14_Db \| 11.77 \| 318.14%	AL354710.17 \| E3_Aa \| 11.95 \| 57514.65%	AL603832.28 \| E2_Aa \| 12.74 \| 18119.09%	AC012652.1 \| E7_Da \| 12.59 \| 1563.75%	AC084398.25 \| E3_Aa \| 12.52 \| 280933.05%
197	CXorf56 \| E7_Ab \| 11.73 \| 1486.32%	OAZ1 \| E2_Da \| 11.77 \| 26.45%	RP4-552O12.1 \| E4_Da \| 11.94 \| 686500.77%	ZNF833 \| E2_Da \| 12.73 \| 146337.80%	FCRLA \| E1_Ab \| 12.57 \| 265.06%	SEC14L4 \| E12_Da \| 12.52 \| 2207036.30%
198	GYPC \| E1_Ab \| 11.73 \| 156.45%	SHMT2 \| E1_Ab \| 11.77 \| 198.40%	C1RL \| E6_Ab \| 11.93 \| 9111.73%	RPL37 \| E2_Ab \| 12.67 \| 5016.34%	HLA-DMA \| E1_Ad \| 12.56 \| 69.45%	HSP90AB3P \| E2_Da \| 12.50 \| 34898.44%
199	C1RL \| E6_Ab \| 11.72 \| 2751.28%	HSP90AB1 \| E13_Ab \| 11.77 \| 25.09%	SERF2 \| E3_Af \| 11.92 \| 298.75%	AL691432.53 \| E16_Aa \| 12.67 \| 5232.91%	AC004448.3 \| E2_Aa \| 12.56 \| 12493.79%	AC021078.5 \| E3_Aa \| 12.49 \| 39417.14%
200	YWHAZ \| E11_Dc \| 11.72 \| 108.83%	ARPC5 \| E1_Ac \| 11.76 \| 95.60%	MORF4L1 \| E1_Ab \| 11.92 \| 205.24%	AC128648.5 \| E8_Aa \| 12.67 \| 3865.77%	FAM169A \| E2_Aa \| 12.55 \| 63001.07%	NUP43 \| E8_Da \| 12.49 \| 2936.34%
201	HSP90AB3P \| E2_Da \| 11.72 \| 77964.23%	DENND1B \| E4_Aa \| 11.76 \| 12598.05%	AGXT2L2 \| E11_Db \| 11.92 \| 1955.17%	NPL \| E7_Da \| 12.67 \| 41096.41%	AC090680.11 \| E5_Aa \| 12.54 \| 759693.35%	AL355076.5 \| E3_Aa \| 12.48 \| 59825.91%
202	AP001605.1 \| E1_Da \| 11.72 \| 8197.53%	NCL \| E5_Dc \| 11.76 \| 62.08%	C17orf87 \| E5_Da \| 11.92 \| 835.17%	AC012652.1 \| E7_Da \| 12.67 \| 1317.67%	ASXL2 \| E2_Aa \| 12.52 \| 6918.84%	HNRPA2B1 \| E9_Ab \| 12.47 \| 101.04%
203	STAG3 \| E32_Aa \| 11.72 \| 573.79%	FAM107B \| E12_Da \| 11.75 \| 104.05%	AL671277.5 \| E8_Da \| 11.91 \| 4809.54%	C1orf130 \| E4_Ab \| 12.67 \| 16724.83%	AL353581.14 \| E4_Aa \| 12.50 \| 4921791.84%	HLA-DMA \| E4_Ab \| 12.47 \| 52.18%
204	KLK7 \| E7_Da \| 11.71 \| 50477.04%	ARPC3 \| E2_Aa \| 11.75 \| 50.02%	AL355076.5 \| E3_Aa \| 11.91 \| 84038.65%	OAZ1 \| E3_Aa \| 12.66 \| 34.37%	UCRC \| E2_Da \| 12.50 \| 412.28%	SERF2 \| E3_Af \| 12.47 \| 219.80%